wp-cerber
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/htdocs/w00e14a1/CPC-NEU2021/wp-includes/functions.php on line 6114[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bbRGBA(255,255,255,0)\u00bb background_image=\u00bbhttps:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/bady-abbas-c4XoMGxfsVU-unsplash-scaled.jpg\u00bb background_blend=\u00bbcolor\u00bb height=\u00bb200px\u00bb max_height=\u00bb200px\u00bb custom_margin=\u00bb-15px||||false|false\u00bb custom_padding=\u00bb||||false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row make_equal=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb||||false|false\u00bb custom_padding_tablet=\u00bb0px||0px||true|false\u00bb custom_padding_phone=\u00bb0px||0px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb custom_css_main_element=\u00bbmargin: auto;\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb header_font=\u00bb|700|||||||\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb45px\u00bb header_font_size_tablet=\u00bb45px\u00bb header_font_size_phone=\u00bb35px\u00bb header_font_size_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbImage left, text right\u00bb _builder_version=\u00bb4.16″ custom_padding=\u00bb0|0px|0px|0px|false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_2,1_2″ use_custom_gutter=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb padding_top_bottom_link_2=\u00bbtrue\u00bb padding_left_right_link_2=\u00bbfalse\u00bb _builder_version=\u00bb4.16″ width=\u00bb100%\u00bb width_tablet=\u00bb80%\u00bb width_phone=\u00bb80%\u00bb width_last_edited=\u00bbon|tablet\u00bb max_width=\u00bb100%\u00bb max_width_tablet=\u00bb80%\u00bb max_width_phone=\u00bb80%\u00bb max_width_last_edited=\u00bbon|tablet\u00bb module_alignment=\u00bbleft\u00bb min_height=\u00bb581.5px\u00bb custom_margin=\u00bb|auto|-89px|auto|false|\u00bb custom_padding=\u00bb0|12%|0px|0px|false|false\u00bb custom_padding_tablet=\u00bb|0%||\u00bb custom_padding_phone=\u00bb\u00bb module_alignment_tablet=\u00bbcenter\u00bb module_alignment_phone=\u00bbcenter\u00bb module_alignment_last_edited=\u00bbon|tablet\u00bb use_custom_width=\u00bbon\u00bb width_unit=\u00bboff\u00bb custom_width_percent=\u00bb100%\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_image src=\u00bbhttps:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/robbie-herrera-lDjxXumgpT8-unsplash-scaled.jpg\u00bb alt=\u00bbGovernment palace of Nuevo Le\u00f3n in Monterrey Mexico\u00bb title_text=\u00bbGovernment palace Mexico\u00bb show_bottom_space=\u00bboff\u00bb force_fullwidth=\u00bbon\u00bb align_tablet=\u00bbcenter\u00bb align_phone=\u00bbcenter\u00bb align_last_edited=\u00bbon|desktop\u00bb _builder_version=\u00bb4.16″ background_color_gradient_direction=\u00bb90deg\u00bb background_color_gradient_start=\u00bb#404451″ background_color_gradient_end=\u00bbrgba(240,242,246,0)\u00bb custom_padding=\u00bb||||false|false\u00bb custom_padding_tablet=\u00bb||60px|\u00bb custom_padding_phone=\u00bb||10px||false|false\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbleft\u00bb animation_intensity_slide=\u00bb1%\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb13px\u00bb custom_padding=\u00bb|||61px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n
Featured image: Photo by Robbie Herrera<\/a> on Unsplash<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ custom_padding=\u00bb6vw||6vw|\u00bb custom_padding_tablet=\u00bb0px|0px|0px|0px|false|true\u00bb custom_padding_phone=\u00bb||||false|false\u00bb custom_padding_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb padding_phone=\u00bb||||false|false\u00bb padding_tablet=\u00bb|10%||10%|false|true\u00bb padding_last_edited=\u00bbon|tablet\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ text_font=\u00bb||||||||\u00bb header_font=\u00bb||||||||\u00bb header_3_text_color=\u00bb#3550a0″ header_6_font=\u00bb||||||||\u00bb max_width=\u00bb827px\u00bb custom_margin=\u00bb-55px|||||\u00bb custom_padding=\u00bb0px|||||\u00bb hover_enabled=\u00bb0″ header_3_font_size_tablet=\u00bb\u00bb header_3_font_size_phone=\u00bb20px\u00bb header_3_font_size_last_edited=\u00bbon|desktop\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n Mexico is one of the most attractive Emerging Markets in the world. Geographically, it lies in Latin America, which contains numerous Emerging Markets. Yet this one is so significant that Mexican Consumer Healthcare and Rx industry deserves particular attention.<\/span><\/i><\/p>\n <\/span><\/i><\/p>\n During the last couple of years, Mexico has grown to be <\/span>one of the leading producers of consumer healthcare and Rx products in the Americas<\/b> as well as the main exporter of OTC and pharma products to Europe and the USA in Latin America.<\/span><\/p>\n The Mexican pharmaceutical market is the <\/span>second-largest Latin American market after Brazil and it accounts for 0,5% of the country\u2019s GDP<\/b>. Mexico\u2019s OTC and prescription market has seen steady growth in the past decade and is projected to reach over <\/span>USD 32,4 Billion <\/b>ex-factory in <\/span>2035<\/b>.<\/span><\/p>\n These high growth rates are mainly attributable to an <\/span>aging population, a growing middle class, a stable business environment<\/b> as well as improved access to health care services that increases the consumer\u2019s demand for OTC and pharma products. Moreover, the government is currently transforming the national health care model to focus on disease prevention due to a noticeable epidemiological transition from communicable to chronic degenerative diseases in Mexico.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb header_3_text_color=\u00bb#001389″ global_colors_info=\u00bb{}\u00bb]<\/p>\n Mexico provides an outstanding example of what can be achieved through the high-level political commitment.<\/span><\/p>\n There are <\/span>three major institutions in the Mexican healthcare system<\/b>:<\/span><\/p>\n The improvements of the regulatory environment as well as the increase in foreign direct investment make Mexico\u2019s consumer healthcare and pharma market more attractive to multinational drug makers.<\/span><\/p>\n <\/span><\/p>\n In recent years the market has been more strictly regulated, and new regulations were implemented.\u00a0<\/span><\/p>\n A change of presidency brought to the signing of the agreement with the United Nations Office for Project Services \u2013 UNOPS, to entrust it with the management of the consolidated purchase of medicines and medical supplies for the period 2021-2024. The agreement covers the entire Consumer Healthcare sector, but there would be only one government institution \u2013 the National Institute of Health for Wellbeing (INSABI) able to coordinate the consolidated purchase of medicine together with UNOPS.<\/span><\/p>\n It is necessary to mention that Mexico works the same way as European countries: Medicines are supplied to pharmacies by <\/span>2-3 major wholesalers<\/b>. Moreover, the role of wholesalers in the Mexican OTC and pharma market has been gradually reduced, and the wholesalers\u2019 functions are being taken over partly by the growing pharmacy chains.<\/span><\/p>\n The Mexican pharmacy business attracts more and more foreign investors. And those who enter the Mexican consumer health and Rx Market with care and local knowledge will be the most successful players in one of the world\u2019s largest economies.<\/span><\/p>\n <\/span><\/p>\n <\/span><\/p>\n has a long-standing network and has extensive experience based on many projects in Mexico. We operate in various global industry segments, such as Consumer Health Care, Medical Devices, Rx, OTC and Cosmetics. We are happy to help you with your international strategy and are here to assist you with Regulatory topics, GMP Certificates, and Market Entry.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbExpert Knowledge\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb609.2px\u00bb custom_margin=\u00bb-67px||-121px|||\u00bb custom_padding=\u00bb75px|||||\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbRow\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb45px\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market size, ex-factory<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_icon font_icon=\u00bb||divi||400″ icon_color=\u00bb#001389″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_icon][et_pb_text _builder_version=\u00bb4.17.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n OTC and pharma market growth<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ admin_label=\u00bbNumber Counter\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#EEEEEE\u00bb custom_margin=\u00bb-28px|||||\u00bb custom_padding=\u00bb7px||17px|||\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbTotal population \u00bb number=\u00bb130 207 371 \u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb65px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMale\/Female \u00bb number=\u00bb0.96″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbPopulation growth \u00bb number=\u00bb1.04%\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbBirth rate \u00bb number=\u00bb17.29\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb number_font_size=\u00bb72px\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbMortality rate \u00bb number=\u00bb5.41\/1000″ percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_number_counter title=\u00bbLife expectancy\u00bb number=\u00bb76.94 years\u00bb percent_sign=\u00bboff\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb number_text_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_cta title=\u00bbInterested in this market?\u00bb button_url=\u00bbhttps:\/\/www.chameleon-pharma.com\/about\/contacts\/\u00bb button_text=\u00bbClick Here\u00bb _builder_version=\u00bb4.16″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#0B0B7A\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n <\/span><\/p>\n We are ready to support you in\u00a0<\/span>Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects,<\/span>\u00a0and more in order to ensure your growth.<\/span><\/p>\n<\/div>\n<\/div>\n [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" MexicoFeatured image: Photo by Robbie Herrera on UnsplashMexico: the huge potential of its Consumer Healthcare and Rx market\u00a0 Mexico is one of the most attractive Emerging Markets in the world. Geographically, it lies in Latin America, which contains numerous Emerging Markets. Yet this one is so significant that Mexican Consumer Healthcare and Rx industry deserves […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":65,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[caption id=\"attachment_1928\" align=\"alignleft\" width=\"431\"] Ciudad de M\u00e9xico <\/a>by Aloud..<\/a>[\/caption]\r\n\r\nDuring the last couple of years, Mexico has grown to be one of the leading producers of pharmaceutical products in the Americas as well as the main exporter of pharmaceutical products to Europe and the USA in Latin America.\r\n\r\nThe Mexican pharmaceutical market is the second largest Latin American market after Brazil and it accounts for 1.5% of the country\u2019s GDP. In 2013, the Mexican healthcare market accounted for 17.6 billion USD, although the market\u2019s sales slowed in 2012-2013. However, experts predict an annual market growth rate of 6.8% until the Mexican pharmaceutical market will be worth approximately 22.5 billion USD in 2020.\r\n\r\nThese high growth rates are mainly attributable to an aging population, a growing middle class, a stale business environment as well as an improved access to health care services that increases the consumer\u2019s demand for pharmaceutical products. Moreover, the government is currently transforming the national health care model to focus on disease prevention due to a noticeable epidemiological transition from communicable to chronic degenerative diseases in Mexico.\r\n\r\nMexico also has one of the largest penetrations of generic products worldwide with 84%, and the generics market is expected to grow further by 12.6% annually during the next couple of years. This estimated growth is mainly due to the expiry of several drug patents as well as the implementation of new laws on bioequivalence. Additionally, the Mexican government further promotes the introduction of generic products at affordable prices to the Mexican pharmaceutical market by both foreign and domestic companies.","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8855","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/comments?post=8855"}],"version-history":[{"count":11,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8855\/revisions"}],"predecessor-version":[{"id":17487,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8855\/revisions\/17487"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/media?parent=8855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Mexico: the huge potential of its Consumer Healthcare and Rx market\u00a0<\/strong><\/h2>\n
The Mexican Self-medication and prescription Market<\/b><\/h3>\n
The Mexican Healthcare system<\/b><\/h3>\n
\n
\n
\n
Market Regulations<\/b><\/h3>\n
Chameleon Pharma Consulting Group<\/b><\/h3>\n
The Mexican OTC and pharma market in 2035<\/h2>\n
USD 32,36 Billion<\/b><\/h3>\n
8-10%<\/b><\/h3>\n
Mexico in numbers<\/h2>\n